Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQQ: 46.01 +1.66%   SPY: 110.89 +1.30%
Discuss Index Tracked By  


  Track the *RXFLU Index  

Swine Flu and Bird Flu Stocks (*RXFLU)

  Today: +0.8%
1-month: -3.2%
All-time: -22.4%
Today vs S&P 500 : -0.5%
1-month vs S&P 500: -1.9%
All-time vs S&P 500: -1.1%
Swine Flu and Bird Flu Stocks
Data since: Jan-01-2008 | Index created by tickerspy
546 members Tracking
  Index Description:

These companies all produce or are investigating production of treatments and vaccines for swine flu, bird flu, and other similar flu-like diseases with pandemic potential. Also included are companies that produce flu diagnostic tests.

       
 
Index Stats
Join tickerspy
Avg. Market Cap: $26.8B
Avg. P/E Ratio: 11.9
Avg. Div Yield: 0.8%
Track over 3,000 pro investors Compare your portfolio to Warren Buffett and others
See what Pro investors are buying / selling
Ken Heebner +2.2%
Bruce Berkowitz +2.0%
George Soros +1.3%
Warren Buffett +1.2%
Portfolio ??? ???
 
Portfolio Detail
 
  Standard View     Performance View     Ideas & Research    
Click a column to sort | Scroll over columns for more information
 
 Ticker Last Trade Today's Change Volume  % of
Daily
Mkt Cap  Div Yield  % off
52wk lw
% from
52wk hg
Alerts
 APT $1.57 +0.03 +1.9% 171,238 144% $35.1M - 11% -79% No Alerts/News
 AVII $2.18 +0.04 +1.9% 1,290,079 76% $240.7M - 96% -3% 1 Alert (0 News) - View
 AZN $51.24 +0.70 +1.4% 660,743 36% $74.1B 4.8% 27% -4% No Alerts/News
 BAX $44.23 +0.23 +0.5% 2,043,049 59% $26.6B 2.6% 10% -29% 1 Alert (0 News) - View
 BCRX $5.36 +0.04 +0.8% 475,489 142% $235.6M - 21% -58% 1 Alert (0 News) - View
 CRXL $19.59 +0.03 +0.1% 56,330 92% $1.5B - 16% -20% No Alerts/News
 DVAX $1.70 -0.02 -1.2% 387,412 101% $147.1M - 53% -49% No Alerts/News
 GILD $34.02 +0.87 +2.6% 11,181,965 82% $28.5B - 7% -31% 1 Alert (0 News) - View
 GNBT $0.41 0.00 +0.5% 1,235,597 61% $103.9M - 32% -59% No Alerts/News
 GSK $39.29 +0.34 +0.9% 2,007,949 112% $111.2B 5.1% 22% -10% 1 Alert (1 News) - View
 HEB $0.51 -0.01 -1.2% 395,419 66% $67.6M - 17% -77% No Alerts/News
 INO $0.99 +0.01 +1.0% 267,501 88% $101.7M - 30% -53% No Alerts/News
 NVAX $2.31 -0.01 -0.4% 389,871 55% $215.9M - 20% -64% No Alerts/News
 NVS $53.10 +0.10 +0.2% 2,078,968 73% $120.7B 3.1% 22% -6% 1 Alert (0 News) - View
 PURE $1.95 +0.07 +3.7% 137,838 81% $66.5M - 60% -48% No Alerts/News
 QDEL $12.00 -0.04 -0.3% 403,703 158% $346.5M - 15% -36% No Alerts/News
 RHHBY $34.86 +0.37 +1.1% 268,124 69% $97.9B 3.4% 10% -23% No Alerts/News
 SNY $30.20 +0.50 +1.7% 1,274,001 57% $79.4B 3.7% 8% -27% 1 Alert (1 News) - View
 SVA $3.68 +0.02 +0.6% 188,126 82% $199.0M - 5% -66% No Alerts/News
 VICL $3.25 +0.01 +0.3% 171,225 88% $182.5M - 22% -41% No Alerts/News
Discuss the Swine Flu and Bird Flu Stocks (*RXFLU)
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
Strong Stocks - PM, UBS, GSK
UBS  GSK  PM  
Linked by mktlines ( track member | ignore member ) - September 04, 03:44PM from (www.patternstocks.com)
Technical charts of PM, UBS and GSK  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
The Unusual Suspects for the Week Ahead
GENZ  CSKI  SKS  THQI  BKS  CIEN  TTWO  CALL  BRCD  ID  RTN  FNFG  NFLX  SNY  NE  NAL  LULU  PBR  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - September 04, 01:09PM from (247wallst.com)
The cast of characters in this week's Unusual Suspects is not any ordinary group of companies. There are many key stocks  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Orexigen Finds A Cautious Partner
ABT  VVUS  RHHBY  ARNA  SNY  OREX  
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - September 03, 11:27AM from (stocks.investopedia.com)
Orexigen gets the going rate for an obesity drug with low expectations.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Generex Oncology Announces Consultancy of Dr. George E. Peoples, MD
GNBT  
Linked by GlobeNewsire ( track newsfeed | ignore newsfeed ) - September 02, 09:30AM from (www.globenewswire.com)
WORCESTER, Mass., Sept. 2, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (Nasdaq:GNBT) today  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Sanofi Ups The Pressure On Genzyme
BMY  AMGN  GENZ  ISIS  SHPGY  SNY  
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - September 01, 12:00PM from (stocks.investopedia.com)
Sanofi has decided to make its intentions public and ratchet up the pressure on GENZ management.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
What It's Like To Get Acquired By And Work At Yahoo
APT  
Linked by Silicon Alley Insider ( track newsfeed | ignore newsfeed ) - September 01, 11:43AM from (www.businessinsider.com)
After finishing over three years at Yahoo! and almost 3 years previous to that at Right Media, I thought it’d be worthwhile  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Generex Biotechnology Initiates Social Media Campaign for Its Corporate and e-Commerce Websites
GNBT  
Linked by GlobeNewsire ( track newsfeed | ignore newsfeed ) - September 01, 09:30AM from (www.globenewswire.com)
WORCESTER, Mass., Sept. 1, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Gilead Provides Update on $5 Billion Stock Repurchase Program
GILD  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - September 01, 08:30AM from (www.businesswire.com)
Gilead Sciences, Inc. (Nasdaq:GILD) today provided an update on the company’s previously announced $5.0 billion stock repurchase  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Over $100 Billion in Buybacks and M&A in August
GPS  HPQ  INTC  MMM  JWN  RSH  SCHW  GENZ  BHP  POT  INTU  VRSN  MRVL  SNY  DYN  PAR  LO  DISCA  DTV  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - August 31, 07:57AM from (247wallst.com)
$100 billion... That is roughly the combined tally of August share buyback announcements and merger announcements. This  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Stocks Return to Losing Ways
HPQ  INTC  MMM  GENZ  DELL  IFNNY  SNY  COGT  IDI  PAR  
Linked by tickerspy Newswire ( track newsfeed | ignore newsfeed ) - August 30, 04:41PM from (www.tickerspy.com)
Despite another flurry of M&A activity, stocks returned to their recent losing ways. For companies with boatloads  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Genzyme Says No to Sanofi-Aventis
INTC  GENZ  SNY  
Linked by CrossingWallStreet.com ( track newsfeed | ignore newsfeed ) - August 30, 01:14PM from (www.crossingwallstreet.com)
The stock market is bucking the trend of 2010 as we’re currently trending lower on a Monday. The market, however, is still  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Stocks Sag On Economic Anxiety
INTC  MMM  GENZ  SPY  MFE  SNY  COGT  
Linked by Forbes ( track newsfeed | ignore newsfeed ) - August 30, 11:13AM from (www.forbes.com)
M&A continues to heat up with a spate of fresh takeovers, but worries over August payrolls tamp down enthusiasm.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Genzyme Rejects Sanofi-Aventis's Buyout Proposal
GENZ  SNY  
Linked by BloggingStocks ( track newsfeed | ignore newsfeed ) - August 30, 10:13AM from (www.bloggingstocks.com)
Over the weekend, French pharmaceutical firm Sanofi-Aventis (SNY) made its attempt to take over biotech firm Genzyme (GENZ)  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Genzyme Rejects $18.5 Billion Offer by Sanofi
GENZ  SNY  
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - August 30, 09:40AM from (feeds.nytimes.com)
The biotechnology company said the offer of $69 a share, which was disclosed on Sunday, undervalued the company.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Sanofi-Aventis Offers $18.5 Billion for Genzyme
GENZ  SNY  
Linked by The Dividend Daily ( track newsfeed | ignore newsfeed ) - August 30, 08:49AM from (www.dividend.com)
French pharma giant Sanofi-Aventis SA (SNY) on Monday officially announced an $18.5 billion takeover bid for biotech company Genzyme Corporation (GENZ).
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Media Digest (8/30/2010) Reuters, WSJ, NYTimes, FT, Bloomberg
HPQ  INTC  BAC  BHP  DELL  POT  NOK  DIS  RIMM  SNY  VMW  SI  CMCSA  GOOG  ORCL  TWC  PAR  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - August 30, 04:11AM from (247wallst.com)
Reuters: The Bank of Japan eased policy to fight a rise in the yen. Reuters: Obama said the economy is not growing fast  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Sanofi Reveals Its Bid for Genzyme
GENZ  SNY  
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - August 29, 01:00PM from (feeds.nytimes.com)
Sanofi-Aventis, the French drug maker, publicly disclosed its $18.5 billion bid for the American biotechnology firm Genzyme  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Generex Informs Stockholders of Minimum Exchange Ratio for Reverse Stock Split Proposal to be Considered at the Special Meeting of Stockholders on September 17, 2010
GNBT  
Linked by GlobeNewsire ( track newsfeed | ignore newsfeed ) - August 27, 04:30PM from (www.globenewswire.com)
WORCESTER, Mass., Aug. 27, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Market Notes: August 27, 2010
LLY  GILD  NICK  
Linked by CrossingWallStreet.com ( track newsfeed | ignore newsfeed ) - August 27, 04:13PM from (www.crossingwallstreet.com)
The Buy List had a very good day to close out August which was an ugly month for us.

Here are a few notes on some of our stocks:
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 84



Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.

Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.

Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.

Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.

Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.

Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.

Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
Index components are equally weighted.
Click to close X

We look at the recent net stock adds (people adding a stock to their portfolio minus people removing it) and compare against the company's previous history to identify those companies that are seeing the largest changes on a relative basis. Without the company history comparison, our most followed companies would likely be near the top of the list at all times. A value greater than one indicates a greater than normal number of adds over the last seven days, and a value less than one indicates a less than normal number of adds. If no value is shown, there was not enough activity to generate a value.

Click to close X

We look at the recent net stock shorts (people shorting it in their portfolios minus people covering their short) and compare against the company's previous history to identify those companies that are seeing the largest changes on a relative basis. A value less than -1 (for example -3.6) indicates a greater than normal number of shorts over the last seven days, and a value greater than -1 (for example -0.6) indicates a less than normal number of adds. If no value is shown, there was not enough activity to generate a value.

Click to close X

Thanks for helping us keep tickerspy Indexes accurate!

Let us know which tickers should be added or removed from the Swine Flu and Bird Flu Stocks Index (*RXFLU).

Note: Our tickerspy research team will look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.


Click to close X

Got an idea for an Index we don't have listed? Send it, and our research team will consider it for inclusion.

Note: Our tickerspy research team look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.

Index Name

Tickers(separate with spaces or commas)

Additional comments